Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00862212 · ClinicalTrials.gov registry record · NA
Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT00862212 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 83 participants.
The verdict
NCT00862212, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to treat individuals with social anxiety disorder with a Food and Drug Administration-approved medication for the treatment of social anxiety disorder, the antidepressant paroxetine, and to evaluate the impact of an intervention designed to help those individuals cope with anxiety without the use of common coping behaviors.
Interventions
- BEHAVIORAL Brief Alcohol Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00862212
The ClinicalTrials.gov registry entry for NCT00862212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Alcohol Intervention is the first listed.
NCT00862212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00862212 about?
NCT00862212 is a clinical study titled "Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting". The purpose of this study is to treat individuals with social anxiety disorder with a Food and Drug Administration-approved medication for the treatment of social anxiety disorder, the antidepressant paroxetine, and to evaluate the impact of an intervention designed to help those individuals cope wi...
What is the current status of trial NCT00862212?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2009-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00862212?
The interventions under investigation include: Brief Alcohol Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00862212?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.